
Photo: bpno.dk
Jun 26, 2025, 09:16
Fredrik Schjesvold: CAR-T for Myeloma is Now Approved in Sweden
Fredrik Schjesvold, Head of Oslo Myeloma Center at Oslo University Hospital, shared a post on LinkedIn:
“Now CAR-T for myeloma is approved also in Sweden, even at first relapse. From before it was already approved in Denmark, at third relapse.
Both other Scandinavian countries have found cilta-cel to be cost-efficient.
More posts featuring Myeloma.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 10:44
Jun 26, 2025, 10:37
Jun 26, 2025, 09:53
Jun 26, 2025, 09:36
Jun 26, 2025, 09:35